We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Truist Financial
TFC
$64.3B
| $10.8M | 0.05% |
277,548
-140,512
| -34% | -$5.31M |
|
327
Southern Copper
SCCO
$165B
| $10.7M | 0.05% |
107,667
+18,721
| +21% | +$1.97M |
|
|
EA
328
DELISTED
Electronic Arts
EA
| $10.7M | 0.05% |
76,846
-17,627
| -19% | -$2.32M |
|
|
XYZ
329
Block Inc
XYZ
$47B
| $10.7M | 0.05% |
165,595
+12,026
| +8% | +$841K |
|
330
Natera
NTRA
$45.5B
| $10.5M | 0.05% |
97,200
+2,600
| +3% | +$264K |
|
331
Healthpeak Properties
DOC
$14.2B
| $10.5M | 0.05% |
534,810
+58,006
| +12% | +$1.11M |
|
332
MSCI
MSCI
$40.9B
| $10.4M | 0.05% |
21,689
+2,722
| +14% | +$1.35M |
|
333
DuPont de Nemours
DD
$19.5B
| $10.4M | 0.05% |
103,250
-62,914
| -38% | -$6.16M |
|
334
Kraft Heinz
KHC
$29.1B
| $10.4M | 0.05% |
322,149
-120,926
| -27% | -$4.31M |
|
335
Ameriprise Financial
AMP
$49.9B
| $10.1M | 0.04% |
23,749
-6,297
| -21% | -$2.69M |
|
336
Capital One
COF
$136B
| $10.1M | 0.04% |
72,767
-9,619
| -12% | -$1.35M |
|
337
BioMarin Pharmaceuticals
BMRN
$13.6B
| $10M | 0.04% |
121,566
+24,754
| +26% | +$2.06M |
|
|
AXON
338
Axon Enterprise
AXON
$48.7B
| $9.97M | 0.04% |
33,902
+19,600
| +137% | +$5.85M |
|
339
Alexandria Real Estate Equities
ARE
$8.27B
| $9.97M | 0.04% |
85,216
+20,651
| +32% | +$2.46M |
|
340
Travelers Companies
TRV
$77.2B
| $9.73M | 0.04% |
47,843
-23,079
| -33% | -$4.96M |
|
341
Packaging Corp of America
PKG
$22.8B
| $9.64M | 0.04% |
52,787
-3,893
| -7% | -$708K |
|
342
Viatris
VTRS
$18.5B
| $9.53M | 0.04% |
896,289
+154,402
| +21% | +$1.71M |
|
343
Ametek
AME
$59.3B
| $9.51M | 0.04% |
57,065
+1,769
| +3% | +$306K |
|
344
Williams-Sonoma
WSM
$28.9B
| $9.39M | 0.04% |
66,520
-35,600
| -35% | -$5.31M |
|
345
Centene
CNC
$33.1B
| $9.35M | 0.04% |
141,091
-10,379
| -7% | -$755K |
|
346
Zscaler
ZS
$28.7B
| $9.25M | 0.04% |
48,110
+9,335
| +24% | +$1.66M |
|
|
DFS
347
DELISTED
Discover Financial Services
DFS
| $9.24M | 0.04% |
70,641
+9,224
| +15% | +$1.15M |
|
348
Coca-Cola Europacific Partners
CCEP
$47.3B
| $9.24M | 0.04% |
126,764
-10,250
| -7% | -$738K |
|
349
PACCAR
PCAR
$69B
| $9.22M | 0.04% |
89,568
-98,363
| -52% | -$10.8M |
|
350
HubSpot
HUBS
$10.5B
| $9.19M | 0.04% |
15,573
+3,368
| +28% | +$2.07M |
|
Similar funds
VIA
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.